XML 72 R32.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Derivative Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2019
Derivative Instruments And Hedging Activities Disclosure [Abstract]  
Schedule of Fair Values of the Company's Derivative Instruments and the Line Items on the Consolidated Balance Sheets

The fair values of the Company’s derivative instruments and the line items on the consolidated balance sheets to which they were recorded as of December 31, 2019, and 2018, are summarized as follows:

 

 

 

Balance Sheet

 

December 31,

 

 

Balance Sheet

 

December 31,

 

 

 

Location

 

2019

 

 

2018

 

 

Location

 

2019

 

 

2018

 

 

 

 

 

(In thousands)

 

 

 

 

(In thousands)

 

Derivatives not designated as hedging instruments

 

Prepaid expenses and other current assets

 

$

109

 

 

$

784

 

 

Other accrued liabilities

 

$

493

 

 

$

331

 

Derivatives designated as hedging instruments

 

Prepaid expenses and other current assets

 

 

43

 

 

 

2

 

 

Other accrued liabilities

 

 

32

 

 

 

37

 

Total

 

 

 

$

152

 

 

$

786

 

 

 

 

$

525

 

 

$

368

 

 

Schedule of Company's Derivative Instruments on Accumulated Other Comprehensive Income and the Consolidated Statement of Operations

The effect of the Company’s derivative instruments on AOCI and the consolidated statements of operations for the years ended December 31, 2019, 2018 and 2017 are summarized as follows:

 

 

 

Year Ended December 31, 2019

 

 

 

2019

 

 

2018

 

 

2017

 

Derivatives designated as hedging instruments:

 

 

 

 

 

 

 

 

 

 

 

 

Cash flow hedges

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forward contracts:

 

 

 

 

 

 

 

 

 

 

 

 

Gains (Losses) recognized in other comprehensive income- Effective Portion

 

$

1,565

 

 

$

1,416

 

 

$

(7,785

)

Gains (Losses) reclassified from accumulated other comprehensive income into Income -Effective Portion (1):

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$

1,929

 

 

$

665

 

 

$

(5,786

)

Cost of revenue

 

$

(12

)

 

$

(9

)

 

$

18

 

Research and development

 

$

(57

)

 

$

83

 

 

$

130

 

Sales and marketing

 

$

(284

)

 

$

(102

)

 

$

788

 

General and administrative

 

$

(41

)

 

$

(53

)

 

$

133

 

Derivatives not designated as hedging instruments:

 

 

 

 

 

 

 

 

 

 

 

 

Gains (Losses) recognized in Other income (expense), net

 

$

1,307

 

 

$

3,870

 

 

$

(5,085

)

 

(1)

Refer to Note 11, Stockholders' Equity, which summarizes the accumulated other comprehensive income activity related to derivatives.